VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 222 filers reported holding VIR BIOTECHNOLOGY INC in Q3 2022. The put-call ratio across all filers is 0.85 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $422,962 | -68.4% | 45,140 | -17.4% | 0.00% | -100.0% |
| Q2 2023 | $1,339,853 | +86.5% | 54,621 | +76.9% | 0.00% | – |
| Q1 2023 | $718,438 | -7.2% | 30,874 | +0.9% | 0.00% | – |
| Q4 2022 | $774,334 | +33.7% | 30,594 | +1.9% | 0.00% | – |
| Q3 2022 | $578,978 | -25.8% | 30,030 | -2.0% | 0.00% | -100.0% |
| Q2 2022 | $780,732 | -35.9% | 30,653 | -35.1% | 0.00% | 0.0% |
| Q1 2022 | $1,218,526 | -6.3% | 47,223 | +50.2% | 0.00% | 0.0% |
| Q4 2021 | $1,301,000 | -5.9% | 31,448 | -1.0% | 0.00% | 0.0% |
| Q3 2021 | $1,382,000 | -16.0% | 31,763 | -8.8% | 0.00% | 0.0% |
| Q2 2021 | $1,646,000 | +2.9% | 34,822 | +11.6% | 0.00% | 0.0% |
| Q1 2021 | $1,599,000 | +80.3% | 31,196 | -5.9% | 0.00% | 0.0% |
| Q4 2020 | $887,000 | -18.5% | 33,137 | +4.6% | 0.00% | 0.0% |
| Q3 2020 | $1,088,000 | +4.0% | 31,687 | +10.0% | 0.00% | 0.0% |
| Q2 2020 | $1,046,000 | +360.8% | 28,807 | +335.7% | 0.00% | – |
| Q1 2020 | $227,000 | – | 6,611 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 1,559,142 | $30,100,000 | 23.79% |
| SB INVESTMENT ADVISERS (UK) LTD | 22,086,280 | $425,823,000 | 3.26% |
| Zebra Capital Management LLC | 40,104 | $773,000 | 2.94% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 130,409 | $2,514,000 | 0.94% |
| CLARK ESTATES INC/NY | 180,000 | $3,470,000 | 0.77% |
| Temasek Holdings (Private) Ltd | 6,036,821 | $116,389,909 | 0.70% |
| SECTOR GAMMA AS | 89,808 | $1,731,000 | 0.45% |
| Capital Impact Advisors, LLC | 13,196 | $360,000 | 0.36% |
| SummerHaven Investment Management, LLC | 24,927 | $481,000 | 0.33% |
| DUALITY ADVISERS, LP | 92,712 | $1,787,000 | 0.20% |